Publications
- Aqueous polystyrene–fluor nanosuspensions for quantifying alpha and beta- radiation (October 2007)
- Nanotemplate-Engineered Nanoparticles Containing Gadolinium for Magnetic Resonance Imaging of Tumors (October 2007)
Welcome to Nanomed Pharmaceuticals®
NanoMed Pharmaceuticals is a specialty pharmaceutical company dedicated to developing improved therapeutic and diagnostic products to treat or detect cancer and other serious diseases. The company's lead product is a nanoparticle formulation of an FDA-approved cancer drug used to treat adults diagnosed with acute myeloid leukemia. This lead product is being developed using Nanotemplate Engineering, the company's proprietary nanoparticle manufacturing technology used to formulate small molecules, peptides, proteins, plasmid DNA, and diagnostic agents. NanoMed is headquartered in Kalamazoo, Michigan.
Lead Product
The compound in NanoMeds lead product is a proven anti-leukemic agent for the treatment of acute leukemias.
Nanotechnology
Discover more about Nanotechnology and Nanotemplate Engineering
Contact Us: t (269) 488-8525 f (269) 488-8544 email
Career Opportunities: view our open positions
Copyright © 2001-2007 NanoMed Pharmaceuticals®, Inc. All rights reserved.